Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy

Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy

This study aims to identify baseline medications that, as a proxy for the diseases they are dispensed for, are associated with increased risk of mortality in COVID-19 patients from two regions in Spain and Italy using real-world data. We conducted a cross-country, retrospective, observational study...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kevin Bliek-Bueno, Sara Mucherino, Beatriz Poblador-Plou, Francisca González-Rubio, Mercedes Aza-Pascual-Salcedo, Valentina Orlando, Mercedes Clerencia-Sierra, Ignatios Ioakeim-Skoufa, Enrico Coscioni, Jonás Carmona-Pírez, Alessandro Perrella, Ugo Trama, Alexandra Prados-Torres, Enrica Menditto, Antonio Gimeno-Miguel
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
COVID-19
medications
drugs
mortality
real-world data
Medicine
R
Acceso en línea:https://doaj.org/article/f9949d5945104aa6931784fdf5b6e67a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f9949d5945104aa6931784fdf5b6e67a

Ejemplares similares